Clinical Trials Browser

Phase 3 × Completed × hetrombopag × Clear all

NCT03976882 2025-05-16

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Phase 3 Completed

Classical hematology

Chemotherapy-Induced Thrombocytopenia